0001209191-15-005233.txt : 20150120
0001209191-15-005233.hdr.sgml : 20150119
20150120172803
ACCESSION NUMBER: 0001209191-15-005233
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150120
FILED AS OF DATE: 20150120
DATE AS OF CHANGE: 20150120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SWAIN PAULA J
CENTRAL INDEX KEY: 0001236934
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 15536880
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 3160 PORTER DRIVE
CITY: PALO LATO
STATE: CA
ZIP: 94304
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-20
0
0000879169
INCYTE CORP
INCY
0001236934
SWAIN PAULA J
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, Human Resources
Common Stock
2015-01-20
4
M
0
17500
3.11
A
38583
D
Common Stock
2015-01-20
4
S
0
17500
74.17
D
21083
D
Non-Qualified Stock Option (right to buy)
3.11
2015-01-20
4
M
0
17500
0.00
D
2016-01-26
Common Stock
17500
51469
D
Represents weighted average sale price. Actual sale prices ranged from $73.19 - $74.81.
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Paula Swain
2015-01-20